These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9671490)

  • 1. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
    Hsu SC; Galceran J; Grosschedl R
    Mol Cell Biol; 1998 Aug; 18(8):4807-18. PubMed ID: 9671490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains.
    Galbiati F; Volonte D; Brown AM; Weinstein DE; Ben-Ze'ev A; Pestell RG; Lisanti MP
    J Biol Chem; 2000 Jul; 275(30):23368-77. PubMed ID: 10816572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
    Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
    Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
    J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification.
    Geng X; Xiao L; Lin GF; Hu R; Wang JH; Rupp RA; Ding X
    FEBS Lett; 2003 Jul; 547(1-3):1-6. PubMed ID: 12860376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct regulation of the Xenopus engrailed-2 promoter by the Wnt signaling pathway, and a molecular screen for Wnt-responsive genes, confirm a role for Wnt signaling during neural patterning in Xenopus.
    McGrew LL; Takemaru K; Bates R; Moon RT
    Mech Dev; 1999 Sep; 87(1-2):21-32. PubMed ID: 10495268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
    Jho EH; Zhang T; Domon C; Joo CK; Freund JN; Costantini F
    Mol Cell Biol; 2002 Feb; 22(4):1172-83. PubMed ID: 11809808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for a nuclear function of beta-catenin in Wnt signaling.
    Cong F; Schweizer L; Chamorro M; Varmus H
    Mol Cell Biol; 2003 Dec; 23(23):8462-70. PubMed ID: 14612392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts.
    Young CS; Kitamura M; Hardy S; Kitajewski J
    Mol Cell Biol; 1998 May; 18(5):2474-85. PubMed ID: 9566868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
    Valenta T; Lukas J; Korinek V
    Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
    Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
    J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway.
    Takemaru K; Yamaguchi S; Lee YS; Zhang Y; Carthew RW; Moon RT
    Nature; 2003 Apr; 422(6934):905-9. PubMed ID: 12712206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
    Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
    Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis.
    Vleminckx K; Kemler R; Hecht A
    Mech Dev; 1999 Mar; 81(1-2):65-74. PubMed ID: 10330485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.